161
Views
0
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

The Ratio of Serum Uric Acid to Glycosylated Haemoglobin as a Predictor of All-Mortality in Elderly Patients with Diabetic Foot Ulcers: A Longitudinal Cohort Study

, , , , , ORCID Icon, , & ORCID Icon show all
Pages 2779-2790 | Received 28 May 2023, Accepted 07 Sep 2023, Published online: 12 Sep 2023

References

  • Doğruel H, Aydemir M, Balci MK. Management of diabetic foot ulcers and the challenging points: an endocrine view. World J Diabetes. 2022;13:27–36. doi:10.4239/wjd.v13.i1.27
  • Armstrong DG, Boulton AJM, Bus SA. Diabetic foot ulcers and their recurrence. N Engl J Med. 2017;376(24):2367–2375. doi:10.1056/NEJMra1615439
  • Armstrong DG, Swerdlow MA, Armstrong AA, Conte MS, Padula WV, Bus SA. Five year mortality and direct costs of care for people with diabetic foot complications are comparable to cancer. J Foot Ankle Res. 2020;13(1):16. doi:10.1186/s13047-020-00383-2
  • Walsh JW, Hoffstad OJ, Sullivan MO, Margolis DJ. Association of diabetic foot ulcer and death in a population-based cohort from the United Kingdom. Diabet Med. 2016;33(11):1493–1498. doi:10.1111/dme.13054
  • Fenech G, Rajzbaum G, Mazighi M, Blacher J. Serum uric acid and cardiovascular risk: state of the art and perspectives. Joint Bone Spine. 2014;81(5):392–397. doi:10.1016/j.jbspin.2014.01.008
  • Sharaf El Din UAA, Salem MM, Abdulazim DO. Uric acid in the pathogenesis of metabolic, renal, and cardiovascular diseases: a review. J Adv Res. 2017;8(5):537–548. doi:10.1016/j.jare.2016.11.004
  • Verma S, Ji Q, Bhatt DL, et al. Association between uric acid levels and cardio-renal outcomes and death in patients with type 2 diabetes: a subanalysis of EMPA-REG OUTCOME. Diabetes Obes Metab. 2020;22(7):1207–1214. doi:10.1111/dom.13991
  • Ioachimescu AG, Brennan DM, Hoar BM, et al. Serum uric acid, mortality and glucose control in patients with Type 2 diabetes mellitus: a PreCIS database study. Diabet Med. 2007;24(12):1369–1374. doi:10.1111/j.1464-5491.2007.02302.x
  • Katsiki N, Papanas N, Fonseca VA, et al. Uric acid and diabetes: is there a link? Curr Pharm Des. 2013;19(27):4930–4937. doi:10.2174/1381612811319270016
  • Katsiki N, Dimitriadis GD, Mikhailidis DP. Serum uric acid and diabetes: from pathophysiology to cardiovascular disease. Curr Pharm Des. 2021;27(16):1941–1951. doi:10.2174/1381612827666210104124320
  • Lee SW, Kim HC, Nam C, et al. Age-differential association between serum uric acid and incident hypertension. Hypertens Res. 2019;42(3):428–437. doi:10.1038/s41440-018-0168-4
  • Chen D, Sun X, Zhao X, Liu Y. Associations of serum uric acid and urinary albumin with the severity of diabetic retinopathy in individuals with type 2 diabetes. BMC Ophthalmol. 2020;20(1):467. doi:10.1186/s12886-020-01713-5
  • Mauer M, Doria A. Uric acid and diabetic nephropathy risk. Contrib Nephrol. 2018;192:103–109.
  • Zhang W, Chen L, Lou M. Association of elevated serum uric acid with nerve conduction function and peripheral neuropathy stratified by gender and age in type 2 diabetes patients. Brain Sci. 2022;12(12):1704. doi:10.3390/brainsci12121704
  • Kaewput W, Thongprayoon C, Rangsin R, et al. The association between serum uric acid and peripheral neuropathy in patients with type 2 diabetes mellitus: a multicenter nationwide crosssectional study. Korean J Fam Med. 2020;41(3):189–194. doi:10.4082/kjfm.18.0205
  • Tseng CH. Independent association of uric acid levels with peripheral arterial disease in Taiwanese patients with Type 2 diabetes. Diabet Med. 2004;21(7):724–729. doi:10.1111/j.1464-5491.2004.01239.x
  • Ye X, Cao Y, Gao F, et al. Elevated serum uric acid levels are independent risk factors for diabetic foot ulcer in female Chinese patients with type 2 diabetes. J Diabetes. 2014;6(1):42–47. doi:10.1111/1753-0407.12079
  • American Diabetes Association. Standards of medical care in diabetes-2017 abridged for primary care providers. Clin Diabetes. 2017;35(1):5–26. doi:10.2337/cd16-0067
  • Liberty IF, Abu Freha N, Baumfeld Y, et al. Prognostic value of glycated hemoglobin for one year mortality following hospitalization in the internal medicine ward. Isr Med Assoc J. 2015;17(5):277–281.
  • Wu S, Wang C, Jia Q, et al. HbA1c is associated with increased all-cause mortality in the first year after acute ischemic stroke. Neurol Res. 2014;36(5):444–452. doi:10.1179/1743132814Y.0000000355
  • Pan W, Lu H, Lian B, et al. Prognostic value of HbA1c for in-hospital and short-term mortality in patients with acute coronary syndrome: a systematic review and meta-analysis. Cardiovasc Diabetol. 2019;18(1):169. doi:10.1186/s12933-019-0970-6
  • Grossman A, Beloosesky Y, Schlesinger A, et al. The association between glycated hemoglobin levels and mortality in non-diabetic elderly subjects. Eur J Intern Med. 2016;27:57–61. doi:10.1016/j.ejim.2015.10.010
  • Vella L, Gatt A, Formosa C. Does baseline hemoglobin a1c level predict diabetic foot ulcer outcome or wound healing time? J Am Podiatr Med Assoc. 2017;107(4):272–279. doi:10.7547/15-176
  • Alberti KGMM, Zimmet PZ. Diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabetic Med. 1998;15:539–553. doi:10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S
  • Lipsky BA, Senneville É, Abbas ZG, et al. Guidelines on the diagnosis and treatment of foot infection in persons with diabetes (IWGDF 2019 update). Diabetes Metab Res Rev. 2020;36. doi:10.1002/dmrr.3280
  • Definition of an older or elderly person. Available from: http://www.who.int/healthinfo/survey/ageingdefnolder/en/. Accessed September 07, 2023.
  • King C, Lanaspa MA, Jensen T, Tolan DR, Sánchez-Lozada LG, Johnson RJ. Uric Acid as a Cause of the Metabolic Syndrome. Contrib Nephrol. 2018;192:88–102.
  • Bhole V, Choi JW, Kim SW, de Vera M, Choi H. Serum uric acid levels and the risk of type 2 diabetes: a prospective study. Am J Med. 2010;123(10):957–961. doi:10.1016/j.amjmed.2010.03.027
  • Kodama S, Saito K, Yachi Y, et al. Association between serum uric acid and development of type 2 diabetes. Diabetes Care. 2009;32(9):1737–1742. doi:10.2337/dc09-0288
  • Xu YL, Xu KF, Bai JL, et al. Elevation of serum uric acid and incidence of type 2 diabetes: a systematic review and meta-analysis. Chronic Dis Transl Med. 2016;2(2):81–91. doi:10.1016/j.cdtm.2016.09.003
  • Lv Q, Meng XF, He FF, et al. High serum uric acid and increased risk of type 2 diabetes: a systemic review and meta-analysis of prospective cohort studies. PLoS One. 2013;8(2):e56864. doi:10.1371/journal.pone.0056864
  • Yan D, Wang J, Jiang F, et al. A causal relationship between uric acid and diabetic macrovascular disease in Chinese type 2 diabetes patients: a Mendelian randomization analysis. Int J Cardiol. 2016;214:194–199. doi:10.1016/j.ijcard.2016.03.206
  • Pafili K, Katsiki N, Mikhailidis DP, Papanas N. Serum uric acid as a predictor of vascular complications in diabetes: an additional case for neuropathy. Acta Diabetol. 2014;51(5):893–894. doi:10.1007/s00592-014-0631-x
  • Xiong Q, Liu J, Xu Y. Effects of uric acid on diabetes mellitus and its chronic complications. Int J Endocrinol. 2019;2019:9691345. doi:10.1155/2019/9691345
  • Hayfron-Benjamin CF, van den Born BJ, Amoah AGB, et al. Associations of serum uric acid levels with macrovascular and renal microvascular dysfunction among individuals from sub-saharan Africa. JAMA Netw Open. 2021;4(10):e2128985. doi:10.1001/jamanetworkopen.2021.28985
  • Chida R, Hisauchi I, Toyoda S, et al. Impact of irbesartan, an angiotensin receptor blocker, on uric acid level and oxidative stress in high-risk hypertension patients. Hypertens Res. 2015;38(11):765–769. doi:10.1038/hr.2015.82
  • Corry DB, Tuck ML. Uric acid and the vasculature. Curr Hypertens Rep. 2006;8(2):116–119. doi:10.1007/s11906-006-0006-y
  • Puddu P, Puddu GM, Cravero E, Vizioli L, Muscari A. Relationships among hyperuricemia, endothelial dysfunction and cardiovascular disease: molecular mechanisms and clinical implications. J Cardiol. 2012;59(3):235–242. doi:10.1016/j.jjcc.2012.01.013
  • Zhang L, Fu G, Deng Y, et al. Risk factors for foot ulcer recurrence in patients with comorbid diabetic foot osteomyelitis and diabetic nephropathy: a 3-year follow-up study. Int Wound J. 2023;20(1):173–182. doi:10.1111/iwj.13861
  • Megallaa MH, Ismail AA, Zeitoun MH, et al. Association of diabetic foot ulcers with chronic vascular diabetic complications in patients with type 2 diabetes. Diabetes Metam Synd. 2019;13(2):1287–1292. doi:10.1016/j.dsx.2019.01.048
  • American Diabetes Association. 7. Obesity management for the treatment of type 2 diabetes: standards of medical care in diabetes-2018. Diabetes Care. 2018;41(Suppl 1):S65–S72. doi:10.2337/dc18-S007